BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33982825)

  • 1. Role of highly sensitive nucleic acid amplification testing for plasma cytomegalovirus DNA load in diagnosis of cytomegalovirus gastrointestinal disease among kidney transplant recipients.
    Taksinwarajarn T; Sobhonslidsuk A; Kantachuvesiri S; Thongprayoon C; Cheungpasitporn W; Bruminhent J;
    Transpl Infect Dis; 2021 Aug; 23(4):e13635. PubMed ID: 33982825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of cytomegalovirus DNA in plasma as an adjunct diagnostic for gastrointestinal tract disease in kidney and liver transplant recipients.
    Durand CM; Marr KA; Arnold CA; Tang L; Durand DJ; Avery RK; Valsamakis A; Neofytos D
    Clin Infect Dis; 2013 Dec; 57(11):1550-9. PubMed ID: 23956167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of an ultrasensitive Cytomegalovirus quantitative nucleic acid test on Cytomegalovirus detection and therapy in renal transplant recipients.
    Beechar VB; Pouch SM; Phadke VK; Karadkhele G; Larsen CP; Woodworth MH
    Transpl Infect Dis; 2024 Feb; 26(1):e14219. PubMed ID: 38158932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of blood and tissue diagnostics for gastrointestinal cytomegalovirus disease in solid organ transplant recipients.
    Fisher CE; Alexander J; Bhattacharya R; Rakita RM; Kirby KA; Boeckh M; Limaye AP
    Transpl Infect Dis; 2016 Jun; 18(3):372-80. PubMed ID: 27004439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Cytomegalovirus Serostatus on Allograft Loss and Mortality Within the First Year After Kidney Transplantation: An Analysis of the National Transplant Registry.
    Bruminhent J; Dajsakdipon T; Ingsathit A; Supaporn T; Prommool S; Watcharananan SP
    Transplant Proc; 2020 Apr; 52(3):829-835. PubMed ID: 32113693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Cytomegalovirus DNAemia in Pediatric Kidney Transplant Recipients After Cessation of Antiviral Prophylaxis.
    Chaiyapak T; Borges K; Williams A; Banh T; Vasilevska-Ristovska J; Allen U; Parekh RS; Hébert D
    Transplantation; 2018 Aug; 102(8):1391-1396. PubMed ID: 29377877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.
    Mori T; Mori S; Kanda Y; Yakushiji K; Mineishi S; Takaue Y; Gondo H; Harada M; Sakamaki H; Yajima T; Iwao Y; Hibi T; Okamoto S
    Bone Marrow Transplant; 2004 Feb; 33(4):431-4. PubMed ID: 14676775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of Torque Teno viral load with CMV and BKV infection in pediatric and adolescent kidney transplant patients.
    Eibensteiner F; Messner I; Uhl P; Bond G; Puchhammer-Stoeckl E; Mueller-Sacherer T; Aufricht C; Rusai K
    J Clin Virol; 2024 Jun; 172():105673. PubMed ID: 38564881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics of Late-Onset Cytomegalovirus Infection After Kidney Transplantation.
    Nuansri S; Kantachuvesiri S; Watcharananan SP; Thongprayoon C; Cheungpasitporn W; Bruminhent J
    Transplant Proc; 2021 Sep; 53(7):2267-2271. PubMed ID: 34404538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of relationship between cytomegalovirus pneumonia and viral load in renal transplant recipients.
    Ye Q; Luo G; He X; Zheng W; Zheng L; Dong X; Xu X; Nilsson-Ehle P; Xu N
    Transplant Proc; 2004 Dec; 36(10):3036-41. PubMed ID: 15686689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors of Cytomegalovirus Disease in Kidney Transplant Recipients: A Single-Center Study in Thailand.
    Chiasakul T; Townamchai N; Jutivorakool K; Chancharoenthana W; Thongprayoon C; Watanatorn S; Avihingsanon Y; Praditpornsilpa K; Srisawat N
    Transplant Proc; 2015 Oct; 47(8):2460-4. PubMed ID: 26518951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the CMV antigenemia test and CMV-DNA PCR results in solid organ transplant recipients].
    Özkarata E; Özbek ÖA; Avkan Oğuz V; Sayıner AA
    Mikrobiyol Bul; 2016 Jan; 50(1):44-52. PubMed ID: 27058328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection.
    Martín-Gandul C; Pérez-Romero P; Sánchez M; Bernal G; Suárez G; Sobrino M; Merino L; Cisneros JM; Cordero E;
    J Clin Virol; 2013 Jan; 56(1):13-8. PubMed ID: 23131346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
    Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
    J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
    Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
    BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipients.
    Boillat Blanco N; Pascual M; Venetz JP; Nseir G; Meylan PR; Manuel O
    Transplantation; 2011 Jan; 91(2):251-5. PubMed ID: 21099744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which CMV viral load threshold should be defined as CMV infection in kidney transplant patients?
    Eshraghi H; Hekmat R
    Transplant Proc; 2015 May; 47(4):1136-9. PubMed ID: 26036538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus load at treatment initiation is predictive of time to resolution of viremia and duration of therapy in hematopoietic cell transplant recipients.
    Tan SK; Waggoner JJ; Pinsky BA
    J Clin Virol; 2015 Aug; 69():179-83. PubMed ID: 26209403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of real time-polymerase chain reaction in determining cytomegalovirus viral DNA load in renal transplant recipients.
    Zhang CB; Lai HY; Xu HT; Wang DG; Xiao F
    Chin Med J (Engl); 2012 Oct; 125(19):3575-7. PubMed ID: 23044327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two quantitative real-time CMV-PCR tests calibrated against the 1st WHO international standard for viral load monitoring of renal transplant patients.
    Mannonen L; Loginov R; Helanterä I; Dumoulin A; Vilchez RA; Cobb B; Hirsch HH; Lautenschlager I
    J Med Virol; 2014 Apr; 86(4):576-84. PubMed ID: 24026892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.